OMEROS
Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.
OMEROS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1994-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.omeros.com
Total Employee:
51+
Status:
Active
Contact:
2066765005
Total Funding:
965.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache
Similar Organizations
![]()
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
![]()
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
![]()
Euthymics Bioscience
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.
![]()
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Oculis
Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
![]()
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
![]()
Current Employees Featured
![]()

![]()

![]()

Founder
![]()
![]()
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-09-07 | Nura | Nura acquired by Omeros | N/A |
Investors List
![]()
CRG
CRG investment in Post-IPO Debt - Omeros
![]()
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
![]()
East West Bank
East West Bank investment in Post-IPO Debt - Omeros
![]()
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
![]()
East West Bank
East West Bank investment in Post-IPO Debt - Omeros
![]()
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
![]()
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Omeros
National Institute of Mental Health
National Institute of Mental Health investment in Grant - Omeros
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Omeros
![]()
Life Sciences Discovery Fund
Life Sciences Discovery Fund investment in Grant - Omeros
Newest Events participated
Official Site Inspections
http://www.omeros.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.05 K
- Host name: 104.20.42.239
- IP address: 104.20.42.239
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
